Just a sample of the Echomail archive
Cooperative anarchy at its finest, still active today. Darkrealms is the Zone 1 Hub.
|    EARTH    |    Uhh, that 3rd rock from the sun?    |    8,931 messages    |
[   << oldest   |   < older   |   list   |   newer >   |   newest >>   ]
|    Message 6,027 of 8,931    |
|    ScienceDaily to All    |
|    New study reviews anti-cancer activity o    |
|    04 May 22 22:30:48    |
      MSGID: 1:317/3 62735345       PID: hpt/lnx 1.9.0-cur 2019-01-08       TID: hpt/lnx 1.9.0-cur 2019-01-08        New study reviews anti-cancer activity of sustained release capsaicin       formulations                Date:        May 4, 2022        Source:        Marshall University Joan C. Edwards School of Medicine        Summary:        A study provides the first published in-depth description        of the anti- cancer activity of capsaicin sustained release        formulations. Capsaicin is naturally found in chili peppers and        is the agent that provides the hot and spicy taste when eating        chili peppers.                            FULL STORY       ==========================================================================       A study by a team of researchers at the Marshall University Joan       C. Edwards School of Medicine provides the first published in-depth       description of the anti-cancer activity of capsaicin sustained release       formulations. Capsaicin is naturally found in chili peppers and is       the agent that provides the hot and spicy taste when eating chili       peppers. Sustained release formulation of capsaicin are being explored       for extended anti-cancer activity.                     ==========================================================================       Recently published in Pharmacology & Therapeutics, a leading medical       review journal in the field of pharmacology, the article chronicles       the growth- suppressive activity of sustained release capsaicin drugs,       including solid dispersion systems, liposomes, phospholipid complexes       and nanoparticles. This is the first publication to provide an in-depth       description of the anti-cancer activity of capsaicin sustained release       formulations. The research team was led by Associate Professor of       Biomedical Sciences Piyali Dasgupta, Ph.D., and Professor of Biomedical       Sciences Monica Valentovic, Ph.D.              "This review article is the first to provide a comprehensive overview of       capsaicin formulations in human cancer," said Dasgupta, corresponding       author on the publication. "Previous publications in the literature       only briefly address sustained release formulations of capsaicin."       The nutritional agent capsaicin displayed robust growth-inhibitory       activity in a diverse array of human cancers. However, the clinical       applications of capsaicin as a viable anti-cancer agent were hindered       by three factors -- poor solubility, low bioavailability and spicy flavor.              "Oral use of capsaicin is associated with unfavorable side effects       such as stomach cramps, nausea, a burning sensation in the gut and       gastrointestinal irritation," said Valentovic, a senior author on the       publication. "A strategy to overcome these drawbacks is the development of       different delivery systems, such as encapsulating capsaicin in long-acting       sustained release drug delivery systems could allow for more consistent       capsaicin levels that could be more efficient as anti-cancer agents."       In addition to Dasgupta and Valentovic, clinical faculty Maria T. Tirona,       M.D., Joshua Hess, M.D., and Paul Finch, M.D., contributed to the       publication as well as co-authors Stephen Richbart, Justin Merritt,       Ashley Cox, Emily Moles and Katie Brown.              This research was supported by the R15 Academic Research Enhancement       Award Grants from the National Institutes of Health (1R15CA161491-01A1,       2R15CA161491- 02, 2R15CA161491-03, R15AI151970-01 and1R15HL145573-01), the       West Virginia IDeA Network of Biomedical Research Excellence (WV-INBRE)       grant (P20GM103434) as well as the National Science Foundation (SURE)       and West Virginia NASA State Grant Consortium.                     ==========================================================================       Story Source: Materials provided by       Marshall_University_Joan_C._Edwards_School_of_Medicine.              Note: Content may be edited for style and length.                     ==========================================================================       Journal Reference:        1. Justin C. Merritt, Stephen D. Richbart, Emily G. Moles, Ashley        J. Cox,        Kathleen C. Brown, Sarah L. Miles, Paul T. Finch, Joshua        A. Hess, Maria T. Tirona, Monica A. Valentovic, Piyali        Dasgupta. Anti-cancer activity of sustained release capsaicin        formulations. Pharmacology & Therapeutics, 2022; 238: 108177 DOI:        10.1016/j.pharmthera.2022.108177       ==========================================================================              Link to news story:       https://www.sciencedaily.com/releases/2022/05/220504135629.htm              --- up 9 weeks, 2 days, 10 hours, 51 minutes        * Origin: -=> Castle Rock BBS <=- Now Husky HPT Powered! (1:317/3)       SEEN-BY: 15/0 106/201 114/705 123/120 129/330 331 153/7715 218/700       SEEN-BY: 229/110 111 317 400 426 428 470 664 700 292/854 298/25 305/3       SEEN-BY: 317/3 320/219 396/45       PATH: 317/3 229/426           |
[   << oldest   |   < older   |   list   |   newer >   |   newest >>   ]
(c) 1994, bbs@darkrealms.ca